The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  DYAI Date:  6/18/2019  1:29 AM
Author:  2K10 Number:  25118 of 25561

DYAI recently uplisted from OTC to NASDAQ recently and rung the closing bell today.

They have a new paradigm in manufacture of biologics, vaccines, and proteins using a specialized, patented strain of fungi.

This seems to be a good summary of the technology:

Anyone following this stock and have thoughts?

I was turned onto this by who wrote it up in March or earlier, just ahead of the uplisting is when I first read about it
Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us